← back to search

Silvia Zucchini

University of Ferrara · IT
Area of research
Cellular and Molecular Neuroscience · Developmental Neuroscience
Research interest
Research interests include Epilepsy, Neuroscience, Biology, Genetic enhancement, Epileptogenesis, and Medicine.
h-index
citations
755
works
28
NIH funding
primary concept
email

Recent publications

Correction: Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applications
Gene Therapy 2026cited by 0position: middledoi
Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applications
Gene Therapy 2025cited by 1position: middledoi
Gene therapy for epilepsy targeting neuropeptide Y and its Y2 receptor to dentate gyrus granule cells
EMBO Reports 2024cited by 10position: middledoi
Circulating <scp>microRNAs</scp> and <scp>isomiRs</scp> as biomarkers for the initial insult and epileptogenesis in four experimental epilepsy models: The <scp>EPITARGET</scp> study
Epilepsia 2024cited by 5position: middledoi
Lack of Direct Effects of Neurotrophic Factors in an In Vitro Model of Neuroinflammation
International Journal of Molecular Sciences 2024cited by 1position: lastdoi
The NLRP3 Inflammasome in Neurodegenerative Disorders: Insights from Epileptic Models
Biomedicines 2023cited by 30position: middledoi
Viral Vector-Based Gene Therapy for Epilepsy: What Does the Future Hold?
Molecular Diagnosis & Therapy 2023cited by 12position: middledoi
Sampling Cerebrospinal Fluid and Blood from Lateral Tail Vein in Rats during EEG Recordings
Journal of Visualized Experiments 2023cited by 1position: lastdoi
JoVE Video Dataset
2023cited by 0position: lastdoi
Low-dose 7,8-Dihydroxyflavone Administration After Status Epilepticus Prevents Epilepsy Development
Neurotherapeutics 2022cited by 19position: middledoi
Antipsychotic drugs counteract autophagy and mitophagy in multiple sclerosis
Proceedings of the National Academy of Sciences 2021cited by 71position: middledoi
Improvement of HSV-1 based amplicon vectors for a safe and long-lasting gene therapy in non-replicating cells
Molecular Therapy — Methods & Clinical Development 2021cited by 15position: middledoi
Implication of sestrin3 in epilepsy and its comorbidities
Brain Communications 2020cited by 8position: lastdoi
Gene Therapy Tools for Brain Diseases
Frontiers in Pharmacology 2019cited by 161position: middledoi
A Matter of Genes: The Hurdles of Gene Therapy for Epilepsy
Epiliepsy currents/Epilepsy currents 2019cited by 16position: middledoi
Personalized Needles for Microinjections in the Rodent Brain
Journal of Visualized Experiments 2018cited by 3position: middledoi
Personalized Needles for Microinjections in the Rodent Brain
Journal of Visualized Experiments 2018cited by 1position: middledoi
Effects of [Nphe <sup>1</sup> , Arg <sup>14</sup> , Lys <sup>15</sup> ] N/OFQ-NH <sub>2</sub> (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress
Journal of Psychopharmacology 2017cited by 30position: lastdoi
Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes
Molecular Therapy — Methods & Clinical Development 2017cited by 23position: middledoi
Is autopsy tissue a valid control for epilepsy surgery tissue in micro<scp>RNA</scp> studies?
Epilepsia Open 2016cited by 12position: middledoi
MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy – comparison with human epileptic samples
Scientific Reports 2015cited by 111position: middledoi
Increased extracellular levels of glutamate in the hippocampus of chronically epileptic rats
Neuroscience 2015cited by 50position: middledoi
Impairment of GABA release in the hippocampus at the time of the first spontaneous seizure in the pilocarpine model of temporal lobe epilepsy
Experimental Neurology 2014cited by 51position: middledoi
Identification of miRNAs Differentially Expressed in Human Epilepsy with or without Granule Cell Pathology
PLoS ONE 2014cited by 40position: firstdoi
Increased excitability in tat-transgenic mice: Role of tat in HIV-related neurological disorders
Neurobiology of Disease 2013cited by 40position: firstdoi
Implication of fibroblast growth factors in epileptogenesis-associated circuit rearrangements
Frontiers in Cellular Neuroscience 2013cited by 23position: middledoi
Bradykinin B2 receptors increase hippocampal excitability and susceptibility to seizures in mice
Neuroscience 2013cited by 18position: middledoi
Bystander Effect on Brain Tissue of Mesoangioblasts Producing Neurotrophins
Cell Transplantation 2012cited by 3position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Michele Simonato · University of Ferrara27 papers (2012–2026)Marie Soukupovà · University of Edinburgh14 papers (2014–2024)Gianluca Verlengia · University of Ferrara9 papers (2013–2026)Mario Barbieri · University of Ferrara8 papers (2012–2023)Anna Binaschi · University of Ferrara7 papers (2012–2018)Chiara Falcicchia · University of Ferrara7 papers (2014–2024)Selene Ingusci · University of Ferrara7 papers (2019–2026) · 7 papers (2021–2026)Paolo Roncon · University of Edinburgh6 papers (2014–2020)Stefano Cattaneo · University of Ferrara6 papers (2019–2026)Laila Asth · University of Ferrara5 papers (2023–2024)Annunziata Guarino · University of Ferrara5 papers (2022–2024)Beatrice Paradiso · University of Padua5 papers (2012–2018)Pietro Marino · University of Ferrara4 papers (2020–2023)Manuela Ferracin · IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola4 papers (2014–2024) · 3 papers (2024–2026)Guido Rubboli · University of Copenhagen3 papers (2014–2016)Giovanna Paolone · University of Ferrara3 papers (2018–2020) · 3 papers (2014–2016) · 3 papers (2014–2016)